UTI Healthcare Fund-Direct Reinvestment Inc Dist cum Cap Wdrl
Equity
Direct
Sector - Healthcare
NAV: ₹ 129.5 as on 31-05-2023
Fund Performance
5 people have invested ₹ 10.8K in UTI Healthcare Fund-Direct Reinvestment Inc Dist cum Cap Wdrl in the last three months
About the Fund
UTI Healthcare Fund-Direct Reinvestment Inc Dist cum Cap Wdrl is an equity fund. This fund was started on 1 January, 2013. The fund is managed by Kamal Gada. The fund could potentially beat inflation in the long-run.
Key parameters
1) UTI Healthcare Fund-Direct Reinvestment Inc Dist cum Cap Wdrl has a NAV of ₹129.5051 as on 31-05-2023.
2) UTI Healthcare Fund-Direct Reinvestment Inc Dist cum Cap Wdrl has ₹683 Cr worth of assets under management (AUM) as on 31-03-2023 and is less than category average.
3) The fund has an expense ratio 1.49 %.
UTI Healthcare Fund-Direct Reinvestment Inc Dist cum Cap Wdrl Overview
 | 1.49% |
 Benchmark | S&P BSE Healthcare PR |
 | ₹683 Cr |
 | 1 January, 2013 |
 | ₹5000/₹500 |
 Exit Load | 1% |
 | No Lock-in |
 TurnOver | 43.4% |
Fund Distribution as on (30-Apr-23)
Size breakup
Large cap
41.4%
Small cap
28.8%
Mid cap
26.8%
Sector Allocation
Health
98.2%
Basic Materials
1.8%
Top Holdings of UTI Healthcare Fund-Direct Reinvestment Inc Dist cum Cap Wdrl as on (30-Apr-23)
Equity Holdings31
UTI Healthcare Fund-Direct Reinvestment Inc Dist cum Cap Wdrl: Monthly Changes Updates
All changes are between Feb'23 and Apr'23
Fund Performance
- This fund’s returns stands at 1.08% whereas the fund’s underlying benchmark Nifty 500 returns stands at -0.73% as on Apr'23
- This fund outperformed Nifty 500 by 1.81% in Apr'23
AUM Change
- AUM of the fund stands at 682.8 Cr as of Apr'23
- AUM increased by 28.3 Cr between Apr'23 and Mar'23
Fund Portfolio Changes
Gainers & Losers in UTI Healthcare Fund-Direct Reinvestment Inc Dist cum Cap Wdrl portfolio as on (30-Apr-23)
Top Growth Drivers | 1M Return |
|---|---|
 Aurobindo Pharma Ltd | 18.6% |
 Divis Laboratories Ltd | 13.7% |
 Dr Reddys Laboratories Ltd | 5.9% |
Peer Analysis
UTI Healthcare Fund-Direct Reinvestment Inc Dist cum Cap Wdrl Fund Manager
Kamal Gada
Fund Manager of UTI Healthcare Fund-Direct Reinvestment Inc Dist cum Cap Wdrl, since 2 May 2022
Top funds managed
Fund Highlights
Very High Risk
Investors understand that their principal will be at Very High Risk
About the fund
This fund has delivered an average annual returns of 12.76% since inception which is less than its category average return of 14.91%
Fund Allocations
This fund has an allocation of 97.81% in Equity, 0% in Debt and 2.19% in Cash related instruments
AUM size ₹683 Cr
This fund has AUM of ₹683 Cr which is less than its category average of ₹ 1299 Cr
Expense Ratio 1.49%
This fund has an expense ratio of 1.49% which is less than its category average expense ratio of 1.52%
Frequently Asked Questions
The current NAV of UTI Healthcare Fund-Direct Reinvestment Inc Dist cum Cap Wdrl is ₹129.51 as on 31-May-2023.
Existing (Absolute + CAGR) as on 31-May-2023.
UTI Healthcare Fund-Direct Reinvestment Inc Dist cum Cap Wdrl | Absolute Returns | CAGR Returns |
1 Month Returns | 0.53% | 0.53% |
6 Month Returns | -1.45% | -1.45% |
1 Year Returns | 5.17% | 5.17% |
3 Years Returns | 50.97% | 14.72% |
5 Years Returns | 98.39% | 14.68% |
With INDmoney, the process of investing is very simple and involves zero commission.
- Click Buy on the fund name.
- Input the amount you are looking to invest.
- Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
- Select your bank account and proceed with Payment.
1.49% as on May 2023
₹683 Cr as on May 2023
Sun Pharmaceuticals Industries Ltd(13.02%), Cipla Ltd Shs Dematerialised(7.71%), Dr Reddy's Laboratories Ltd(7.51%), Apollo Hospitals Enterprise Ltd(6.27%), Ajanta Pharma Ltd(4.46%) as on May 2023
The alpha ratio for the UTI Healthcare Fund-Direct Reinvestment Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
UTI Healthcare Fund-Direct Reinvestment Inc Dist cum Cap Wdrl | 0.75 | 0.98 | 1.95 |
As on May 2023
The alpha for UTI Healthcare Fund-Direct Reinvestment Inc Dist cum Cap Wdrl is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the UTI Healthcare Fund-Direct Reinvestment Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
UTI Healthcare Fund-Direct Reinvestment Inc Dist cum Cap Wdrl | 0.87 | 0.94 | 0.91 |
As on May 2023
The Beta for UTI Healthcare Fund-Direct Reinvestment Inc Dist cum Cap Wdrl is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the UTI Healthcare Fund-Direct Reinvestment Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
UTI Healthcare Fund-Direct Reinvestment Inc Dist cum Cap Wdrl | -0.63 | 0.74 | 0.46 |
As on May 2023
The sharpe ratio for UTI Healthcare Fund-Direct Reinvestment Inc Dist cum Cap Wdrl is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the UTI Healthcare Fund-Direct Reinvestment Inc Dist cum Cap Wdrl for various period is as follows:
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
UTI Healthcare Fund-Direct Reinvestment Inc Dist cum Cap Wdrl | 12.37 | 15.52 | 18.9 |
As on May 2023
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 1.33 as on May 2023. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Information ratio is 0.14 as on May 2023. It tells the consistency of the fund in generating superior risk-adjusted performance
Kamal Gada is the fund manager of UTI Healthcare Fund-Direct Reinvestment Inc Dist cum Cap Wdrl
The Exit load of UTI Healthcare Fund-Direct Reinvestment Inc Dist cum Cap Wdrl is 1%